mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.1 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.1 |
mRNA |
GNF-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.1 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.1 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.1 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.1 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.1 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.1 |